A
Amy C. Hessel
Researcher at University of Texas MD Anderson Cancer Center
Publications - 52
Citations - 1769
Amy C. Hessel is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Radiation therapy. The author has an hindex of 18, co-authored 48 publications receiving 1308 citations. Previous affiliations of Amy C. Hessel include University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Rodabe N. Amaria,Sangeetha M. Reddy,Hussein Abdul-Hassan Tawbi,Michael A. Davies,Merrick I. Ross,Isabella C. Glitza,Janice N. Cormier,Carol M. Lewis,Wen-Jen Hwu,Ehab Y. Hanna,Adi Diab,Michael K. Wong,Richard E. Royal,Neil D. Gross,Randal S. Weber,Stephen Y. Lai,Richard A. Ehlers,Jorge Blando,Denái R. Milton,Scott E. Woodman,Robin Kageyama,Daniel K. Wells,Patrick Hwu,Sapna Pradyuman Patel,Anthony Lucci,Amy C. Hessel,Jeffrey E. Lee,Jeffrey E. Gershenwald,Lauren Simpson,Elizabeth M. Burton,Liberty Posada,Lauren E. Haydu,Linghua Wang,Shaojun Zhang,Alexander J. Lazar,Courtney W. Hudgens,Vancheswaran Gopalakrishnan,Alexandre Reuben,Miles C. Andrews,Christine N. Spencer,Victor G. Prieto,Padmanee Sharma,James P. Allison,Michael T. Tetzlaff,Jennifer A. Wargo +44 more
TL;DR: The feasibility of neoadjuvant immune checkpoint blockade in melanoma is described and the need for additional studies to optimize treatment regimens and to validate putative biomarkers is emphasized.
Journal ArticleDOI
Merkel Cell Carcinoma of the Head and Neck: Effect of Surgical Excision and Radiation on Recurrence and Survival
Ann M. Gillenwater,Amy C. Hessel,William H. Morrison,M. Andrew Burgess,Elvio G. Silva,Dianna Roberts,Helmuth Goepfert +6 more
TL;DR: The use of postoperative radiation therapy was associated with a significant improvement in locoregional control and survival rates and future therapeutic innovations should be directed toward controlling the development of distant metastases in patients with Merkel cell carcinoma.
Journal ArticleDOI
Quality and Performance Indicators in an Academic Department of Head and Neck Surgery
Randal S. Weber,Carol M. Lewis,Scott D. Eastman,Ehab Y. Hanna,Olubumi Akiwumi,Amy C. Hessel,Stephen Y. Lai,Leslie Kian,Michael E. Kupferman,Dianna B. Roberts +9 more
TL;DR: Performance measures following oncologic procedures were significantly affected by comorbid conditions and by procedure acuity, and although the latter most strongly affects quality and performance indicators, both should weigh heavily in physician comparisons.
Journal ArticleDOI
Complications, hospital length of stay, and readmission after total laryngectomy
Ryan P. Goepfert,Katherine A. Hutcheson,Jan S. Lewin,Neha G. Desai,Mark Zafereo,Amy C. Hessel,Carol M. Lewis,Randal S. Weber,Neil D. Gross +8 more
TL;DR: The purpose of this study was to describe the 30‐day incidence of complications after total laryngectomy in a high‐volume institution and their impact on the hospital length of stay (LOS) and readmission rates.
Journal ArticleDOI
Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines.
Carol M. Lewis,Amy C. Hessel,Dianna B. Roberts,Yunxia Z. Guo,F. Christopher Holsinger,Lawrence E. Ginsberg,Adel K. El-Naggar,Randal S. Weber +7 more
TL;DR: Evaluating the prereferral treatment of patients referred to the authors' tertiary care center with recurrent or persistent head and neck cancer for compliance with National Comprehensive Cancer Network (NCCN) guidelines concluded that measures to ensure that patients receive therapy according to guidelines should be a national priority.